Company / Cost of Revenue
Avanos Medical, Inc. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$347.3M
FY2025
5-year range
$287.8M / $347.3M
FY2021-FY2025
Trend
+13.3%
vs FY2024
Sector context
#71 of 107
Health Care
What the data says
At $347M, Avanos Medical, Inc.'s cost of revenue ranks #37 of 107 in the Health Care sector. Cost of Revenue has increased for 4 consecutive years, from $288M in FY2021 to $347M in FY2025.
Based on SEC 10-K filings.
$347M in FY2025 with a 5-year CAGR of +0.2%.
Increased from $294M to $347M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +6.2%
- 5-Year CAGR
- +0.2%
- 10-Year CAGR
- -
Sector benchmark
#37 of 107 in Health CareTop 34% of 107This company $347.3M Sector average $11.8B
▼
-97.1% below sector average
Key checks
Key Insights
- Avanos Medical, Inc.'s cost of revenue has grown for 4 consecutive years.
- 5-year CAGR of +0.2%, indicating consistent growth.
- In FY2025, cost of revenue increased 13.3% year-over-year.
- Ranks #71 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $347.3M | +13.3% |
| FY2024 | $306.5M | +4.4% |
| FY2023 | $293.6M | +1.3% |
| FY2022 | $289.9M | +0.7% |
| FY2021 | $287.8M | -16.3% |
| FY2020 | $343.9M | +16.4% |
| FY2019 | $295.4M | +13.0% |
| FY2018 | $261.4M | -4.8% |
| FY2017 | $274.7M | +2.1% |
| FY2016 | $269.0M | +7.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026